- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | Pfizer, Myovant begin dosing in relugolix contraceptive study | ||
| Mi | Gilead's Trodelvy scores accelerated approval in advanced bladder cancer | ||
| Mi | NICE publishes new guidance on chronic pain management | ||
| Mi | UK trial evaluating 'mix and match' COVID-19 vaccine regimens expanded | ||
| Di | Antibiotic Research UK launches small research grants programme | ||
| Di | Experts call for advanced radiotherapy funding to address COVID-19 cancer care backlog | ||
| Di | Inhaled asthma drug accelerates recovery from COVID-19 | ||
| Di | Four medicines accepted for use by NHS Scotland | ||
| Mo | US approval for first AI device to help detect colon cancer | ||
| Mo | C4X Discovery agrees licensing deal with Sanofi | ||
| Mo | Early promise for new immunotherapy combo in brain cancer | ||
| Mo | Farxiga fails to achieve statistical significance in COVID-19 trial | ||
| Mo | Take the next step into CROY 2021 | ||
| Fr | EU nod for new formulation of Biogen's Tysabri | ||
| Fr | NICE 'no' for Opdivo/Yervoy lung cancer combo | ||
| Fr | Human trials for world's first AI-designed immuno-oncology drug | ||
| Fr | Lilly, Incyte's Olumiant fails in COVID-19 trial | ||
| 08.04. | Achilles Therapeutics' US IPO closed with proceeds of $175m | ||
| 08.04. | Novartis bags EU, UK licences for MS therapy Kesimpta | ||
| 08.04. | Benefits of AZ vaccine outweigh risks, says MHRA | ||
| 08.04. | Coronavirus infections drop but R number remains at 1 | ||
| 07.04. | Novartis UK announces further HRT patch stock issues | ||
| 07.04. | Nationwide launch for pioneering fertility study | ||
| 07.04. | Artios, Novartis form cancer therapies collaboration | ||
| 07.04. | Fund opens to boost UK life sciences manufacturing |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
